2017
DOI: 10.4172/2167-0951.1000147
|View full text |Cite
|
Sign up to set email alerts
|

An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia

Abstract: Objective: To assess the safety and efficacy of the metallopeptide zinc-thymulin (ZT) for treating androgenetic alopecia (AGA). Previous in vitro studies have described that different thymic peptides can both increase and decrease anagen (thymulin and thymosin beta-4, respectively). Zinc is an essential element and serum zinc deficiency can cause hair loss. Methods: Eighteen consecutive adult subjects were recruited, 17 males and 1 female, age range 35-90 years (mean 55.4, SD 13.3) with a diagnosis of AGA, Nor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Stem cells for hair loss particularly for androgenetic alopecia have been in development for several years [16]. Thymulin peptide attached to zinc has been found to be safe and effective in humans for stimulating the anagen phase of hair growth and could possibly increase the rate of hair growth after radiotherapy [17].…”
Section: Stem Cellsmentioning
confidence: 99%
“…Stem cells for hair loss particularly for androgenetic alopecia have been in development for several years [16]. Thymulin peptide attached to zinc has been found to be safe and effective in humans for stimulating the anagen phase of hair growth and could possibly increase the rate of hair growth after radiotherapy [17].…”
Section: Stem Cellsmentioning
confidence: 99%